No skullduggery involved in pharma equiry submission switch says EPO
On Monday, the IP Kat blog ran a worrying story about apparent changes to the European Patent Office's submission to the DG Compeition's on-going enquiry into the pharmaceutical sector. IP Kat co-author Jeremy Phillips, who many of you will…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Register now
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe now